Security key
29273B401
ENDRA Life Sciences Inc. - Common Stock, $0.0001 par value (NDRA)
CUSIP: 29273B401
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 168,803
- Total 13F value
- $32,937
- Share change
- +168,803
- SEC-reported price per share
- $0.20
- Number of holders
- 10
- Value change
- +$32,937
- Number of buys
- 10
- Shares outstanding
- 1,986,788
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
10
Top holders
10
NDRA full security history
Ownership snapshot
Full 13F holder table
ENDRA Life Sciences Inc. SEC filings
ENDRA Life Sciences Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of NDRA - ENDRA Life Sciences Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HRT FINANCIAL LP
Disclosed value leader
HRT FINANCIAL LP
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
3/4/5
Lead comparable stake: 28%
Showing 1-6 of 15 holder rows.
Quick read
HRT FINANCIAL LP leads the comparable SEC ownership view at 28%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HRT FINANCIAL LP's linked filing trail.
Comparable ownership
Top 5
HRT FINANCIAL LP
28%
JANE STREET GROUP, LLC
9.9%
GEODE CAPITAL MANAGEMENT, LLC
6.4%
UBS Group AG
4.7%
VANGUARD GROUP INC
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HRT FINANCIAL LP |
13F
Company
|
28%
|
$32,000
329,571 shares
|
— | 30 Jun 2024 |
| JANE STREET GROUP, LLC |
13F
Company
|
9.9%
|
$11,353
116,914 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
6.4%
|
$7,398
76,171 shares
|
— | 30 Jun 2024 |
| UBS Group AG |
13F
3/4/5
Company · Market maker/broker-dealer
|
4.7%
|
$5,379
55,453 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.4%
|
$3,866
39,812 shares
|
— | 30 Jun 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
3.2%
|
$3,674
37,838 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
168,803
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
0
Q3 2024 holders
10
Holder diff
10
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|